These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 17761373)
41. Melphalan and its role in the management of patients with multiple myeloma. Falco P; Bringhen S; Avonto I; Gay F; Morabito F; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2007 Jul; 7(7):945-57. PubMed ID: 17627453 [TBL] [Abstract][Full Text] [Related]
42. The evolving background for high-dose treatment for myeloma. Sirohi B; Powles R; Harousseau JL; Anderson KC Bone Marrow Transplant; 2007 Dec; 40(12):1097-100. PubMed ID: 17906702 [TBL] [Abstract][Full Text] [Related]
43. An update: health economics of managing multiple myeloma. Moeremans K; Annemans L Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867 [TBL] [Abstract][Full Text] [Related]
44. Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation. Sharma A; Lokeshwar N; Raina V; Mohanti BK; Kumar R Natl Med J India; 2007; 20(3):121-4. PubMed ID: 17867615 [TBL] [Abstract][Full Text] [Related]
45. Lenalidomide and its role in the management of multiple myeloma. Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796 [TBL] [Abstract][Full Text] [Related]
46. Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT. Kumar SK; Dingli D; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA Bone Marrow Transplant; 2008 Jun; 41(12):1013-9. PubMed ID: 18332915 [TBL] [Abstract][Full Text] [Related]